相关实验视频
Updated: Jul 18, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.6K
通过在异质信息网络中的基于元路的特征学习来预测药物副作用关联的可解释框架
概括
这项研究介绍了MPGNN-DSA,这是一种用于预测药物副作用 (DSA) 的新型计算方法. 它有效地利用多个数据库并捕捉复杂的关系,改善药物安全监督.
科学领域:
- 生物医学信息学 生物医学信息学
- 计算药理学计算药理学
- 药物发现 药物发现 药物发现
背景情况:
- 准确识别药物副作用 (DSAs) 对药物开发和安全监测至关重要.
- 传统的DSA识别方法耗时,昂贵,并且可能不完整.
- 现有的计算方法往往无法完全整合多个数据库,捕获复杂的语义或提供可解释性.
研究的目的:
- 开发一种新的计算方法,用于预测药物副作用关联 (DSA).
- 解决现有方法的局限性,包括数据未充分利用,语义捕获不足和缺乏可解释性.
- 通过准确的DSA预测,加强药物安全监测和药物开发.
主要方法:
- 构建一个整合多个生物数据集的异质信息网络 (HIN).
- 应用基于元路径的特征学习模块,以捕捉HIN中的复杂药物副作用语义.
- 开发一个预测模块,利用学习特征进行DSA预测和可解释性.
主要成果:
- 拟议的MPGNN-DSA模型在预测药物副作用关联方面表现出显著的有效性.
- 基于元路径的方法成功地捕获了药物和副作用之间的复杂语义.
- 该方法为预测的DSA提供了可解释性,提高了可解释性.
结论:
- MPGNN-DSA为药物副作用关联预测提供了一种可行和有效的解决方案.
- 该模型能够整合多样化的数据并提供可解释的预测,这有助于推进计算药理学.
- 这种方法有望提高药物安全性,加快药物开发过程.
更多相关视频
相关概念视频
Combined Effects of Drugs: Synergism
4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.0K
Combined Effects of Drugs: Antagonism
8.6K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.6K
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Structure-Activity Relationships and Drug Design
768
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
768
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96

